We know we face challenges achieving our goal. We're competing with other biotech hubs — not only in the U.S., but globally — for talent, funding, partnerships and other resources. Nearly every state in the U.S., most developed countries and many developing countries are targeting the bioscience industry as a driver for growing their economies. While other top-ranking biotech hubs, such as Boston and San Francisco, may have experienced a more organic evolution to top-tier status, our region is unique in the sense that it spans two states and the District of Columbia, all of which have differing governments, values and cultures, adding greater complexity. The size of our region also presents geographical limitations, with more distance between existing and potential collaborators.